| Hasten Biopharmaceutic (Switzerland) AG - Hanarbe 40 mg, Tabletten | | 69936 | | 02 | | Hanarbe 40 mg | | Tabletten | | C09CA09 | | Azilsartan Medoxomil | | 08.08.2024 | | |
| | Composition | | azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg. | | Packungsbestandteile | | Tablets | | | | Active Agent | Dose |
|---|
| Azilsartanum Medoxomilum | 40 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Fumaricum | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | Hydroxypropylcellulosum | | | Magnesii Stearas | | | Mannitol | | | Sodium Hydroxide | | | Sodium | 1.6 mg | | Pro Compresso | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 28 | | | B | | Yes | | 005 | 98 | | | B | | Yes | | 006 | 14 | | | B | | Yes |
|
|
